Does FOSAPREPITANT DIMEGLUMINE Cause Injection site induration? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Injection site induration have been filed in association with FOSAPREPITANT DIMEGLUMINE (Fosaprepitant). This represents 1.9% of all adverse event reports for FOSAPREPITANT DIMEGLUMINE.
17
Reports of Injection site induration with FOSAPREPITANT DIMEGLUMINE
1.9%
of all FOSAPREPITANT DIMEGLUMINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site induration From FOSAPREPITANT DIMEGLUMINE?
Of the 17 reports.
Is Injection site induration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT DIMEGLUMINE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does FOSAPREPITANT DIMEGLUMINE Cause?
Dyspnoea (142)
Pyrexia (136)
Nausea (130)
Infusion related reaction (83)
Diarrhoea (80)
Vomiting (71)
Rash (66)
Hypersensitivity (65)
Stomatitis (64)
Decreased appetite (62)
What Other Drugs Cause Injection site induration?
ETANERCEPT (1,451)
NALTREXONE (866)
ADALIMUMAB (577)
GLATIRAMER (382)
DUPILUMAB (376)
INTERFERON BETA-1A (254)
EVOLOCUMAB (229)
ENBREL (218)
LEUPROLIDE (207)
IXEKIZUMAB (177)
Which FOSAPREPITANT DIMEGLUMINE Alternatives Have Lower Injection site induration Risk?
FOSAPREPITANT DIMEGLUMINE vs FOSCARBIDOPA\FOSLEVODOPA
FOSAPREPITANT DIMEGLUMINE vs FOSCARNET
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN TROMETHAMINE
FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL